Regeneron Pharmaceuticals / Director, Health Economics and Outcomes Research
Susan H. Boklage has been a Director in Health Economic and Outcomes Research, covering both Praluent and Kevzara during her almost 5 year tenure. Prior to Regeneron, she held similar positions at Otsuka America Pharmaceutical, Inc. and Bayer Healthcare Pharmaceuticals. Prior to joining Bayer, Ms. Boklage has held a variety of positions in the pharmaceutical as well as the insurance industry during her 25 year career, providing statistical consulting to pharmaceutical clients, as well as sales and marketing personnel on statistical methodology. She also led a group within a regional commercial insurance company, developing predictive models for risk assessment for underwriting applications.
Ms. Boklage’s expertise is in custom outcomes studies utilizing commercially available medical datasets such as electronic medical records and administrative claims data. Additionally, her background in a variety of statistical methods for real world data provides insight beyond traditional descriptive methods.
Ms. Boklage received dual master’s degrees in Applied Statistics from Villanova University and Public Health from Columbia University’s Mailman School of Public Health.